Prosthetic joint infection: Diagnosis and treatment Werner Zimmerli Invited Commentary Pages: 377 - 379
Use of linezolid against multidrug-resistant gram-positive infections Allan R. Tunkel Clinical Trials Report Pages: 387 - 388
Use of lexipafant in patients with severe sepsis Allan R. Tunkel Clinical Trials Report Pages: 388 - 389
Fluconazole versus amphotericin B in febrile neutropenic patients with cancer Allan R. Tunkel Clinical Trials Report Pages: 389 - 390
Multidrug-resistant pathogens: Mechanisms of resistance and epidemiology Keith S. KayeDonald Kaye OriginalPaper Pages: 391 - 398
Impact of antimicrobial resistance on the treatment of invasive pneumococcal infections Paulo RochaCarlos BaleeiroAllan R. Tunkel OriginalPaper Pages: 399 - 408
Impact of antibiotic resistance on the treatment of gram-negative sepsis Lindsey R. BadenBarry I. Eisenstein OriginalPaper Pages: 409 - 416
Increasing antimicrobial resistance: Therapeutic implications for enterococcal infections Matthew E. LevisonSudhakar Mallela OriginalPaper Pages: 417 - 423
Diabetic foot infection: Conservative treatment outcomes Ellie J. C. Goldstein Clinical Trials Report Pages: 431 - 431
Methicillin-resistant staphylococcus aureus Ellie J. C. Goldstein Clinical Trials Report Pages: 431 - 432
From animal to man: Tinea barbae Gregory W. RuteckiRebecca WurtzRichard B. Thomson OriginalPaper Pages: 433 - 437
Current management of onychomycosis and dermatomycoses James Q. Del Rosso OriginalPaper Pages: 438 - 445
Dog bites: Bacteriology, management, and prevention Fredrick M. Abrahamian OriginalPaper Pages: 446 - 453
The changing epidemic of HIV Scott KellermanPascale WortleyPatricia Fleming OriginalPaper Pages: 457 - 465